A

Akari Therapeutics plc
D

AKTX

1.00000
USD
0.01
(0.50%)
مغلق
حجم التداول
0
الربح لكل سهم
-3
العائد الربحي
-
P/E
-0
حجم السوق
26,471,960
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRX
    0
    (0%)
    0.000000 USD
    A
    ADMA
    -0.450
    (-2.52%)
    17.440 USD
    A
    ARCT
    0.680
    (4.59%)
    15.500 USD
    A
    ARWR
    -0.020
    (-0.10%)
    19.450 USD
    A
    AXSM
    1.160
    (1.29%)
    90.840 USD
    C
    CAPR
    0.180
    (1.40%)
    13.080 USD
    C
    CPRX
    -0.160
    (-0.75%)
    21.270 USD
    I
    IMV
    0.01000
    (1.96%)
    0.51000 USD
    المزيد
الأخبار

العنوان: Akari Therapeutics plc

القطاع: Healthcare
الصناعة: Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).